Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab

AuthID
 P-005-137
27
Author(s)
Li, WM
·
Henitz, ED
·
Favis, R
·
Gaffney, D
·
Shapiro, A
·
[+2]·
[+1]·
[+2]·
[+2]·
Crump, M
·
Shpilberg, O
·
Cakana, A
·
Mulligan, G
·
View all authors
Document Type
Article
Year published
2013
Published
in CLINICAL CANCER RESEARCH, ISSN: 1078-0432
Volume: 19, Issue: 9, Pages: 2551-2561 (11)
Indexing
Wos®
Scopus®
Crossref®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 23549871
Scopus: 2-s2.0-84877088158
Wos: WOS:000318361900028
Source Identifiers
ISSN: 1078-0432
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Coiffier, B;   2 Li, WM;   3 Henitz, ED;
4 Karkera, JD;   5 Favis, R;   6 Gaffney, D;
7 Shapiro, A;   8 Theocharous, P;   9 Elsayed, YA;
10 van de Velde, H;   11 Schaffer, ME;   12 Osmanov, EA;
13 Hong, XN;   14 Scheliga, A;   15 Mayer, J;
16 Offner, F;   17 Rule, S;   18 Teixeira, A;
19 Romejko Jarosinska, J;   20 de Vos, S;   21 Crump, M;
22 Shpilberg, O;   23 Zinzani, PL;   24 Cakana, A;
25 Esseltine, DL;   26 Mulligan, G;   27 Ricci, D;

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service